Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Lara M. Munín Sánchez(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Jesús García-Donás(Universidad San Pablo CEU), María Apellániz-Ruiz(Navarrabiomed), Maria J. Merino(National Institutes of Health), María Sereno(Hospital Universitario Infanta Sofía), Isabel Calvo(Centro Oncológico de Galicia), Juan María Roldán‐Romero(European Bioinformatics Institute), Bruna Calsina(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), María Santos(Spanish National Cancer Research Centre), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Laura Remacha(Spanish National Cancer Research Centre), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Beatriz Castelo, María Currás(Spanish National Cancer Research Centre), Rocío Letón, Eva Guerra(Hospital Universitario Ramón y Cajal), Gerardo Gutiérrez‐Gutiérrez(Erasmus University Rotterdam)
Cited by 37
Related Papers
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394